Your browser doesn't support javascript.
loading
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
van Breemen, Richard B; Muchiri, Ruth N; Bates, Timothy A; Weinstein, Jules B; Leier, Hans C; Farley, Scotland; Tafesse, Fikadu G.
Afiliación
  • van Breemen RB; Linus Pauling Institute, Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2900 SW Campus Way, Corvallis, Oregon 97331, United States.
  • Muchiri RN; Linus Pauling Institute, Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, 2900 SW Campus Way, Corvallis, Oregon 97331, United States.
  • Bates TA; Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
  • Weinstein JB; Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
  • Leier HC; Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
  • Farley S; Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
  • Tafesse FG; Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, United States.
J Nat Prod ; 85(1): 176-184, 2022 01 28.
Article en En | MEDLINE | ID: mdl-35007072

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Cannabinoides / Internalización del Virus / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Nat Prod Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Cannabinoides / Internalización del Virus / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Nat Prod Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos